Medtronic (MDT) Tops Q2 Estimates and Raises FY26 Outlook
Medtronic beat Q2 estimates with $9.0 billion in revenue and $1.36 EPS, lifting its full-year guidance.
BTC$59,122.00-1.06%
ETH$1,558.70-1.78%
USDT$0.9986+0.00%
USDC$0.9996-0.01%
XRP$1.03-2.54%
SOL$65.85-0.94%
TRX$0.3235-0.67%
FIGR_HELOC$1.03-0.49%
HYPE$61.33+2.82%
DOGE$0.0734-1.03%
USDS$0.9996+0.00%
RAIN$0.0157-0.45%
LEO$9.35-0.70%
ZEC$396.61-0.83%
XLM$0.1764-4.24%
BTC$59,122.00-1.06%
ETH$1,558.70-1.78%
USDT$0.9986+0.00%
USDC$0.9996-0.01%
XRP$1.03-2.54%
SOL$65.85-0.94%
TRX$0.3235-0.67%
FIGR_HELOC$1.03-0.49%
HYPE$61.33+2.82%
DOGE$0.0734-1.03%
USDS$0.9996+0.00%
RAIN$0.0157-0.45%
LEO$9.35-0.70%
ZEC$396.61-0.83%
XLM$0.1764-4.24%
AECOM beat Q4 EPS expectations at $1.36 but missed revenue at $4.18 billion, and the company expects solid growth heading into fiscal 2026.
Medtronic beat Q2 estimates with $9.0 billion in revenue and $1.36 EPS, lifting its full-year guidance.
Home Depot topped Q3 revenue expectations with $41.4 billion but missed EPS estimates at $3.74, leading to revised 2025 guidance.
J & J Snack Foods beat Q4 expectations with EPS of $1.58 and revenue of $410.24 million, signaling confidence in its growth plans.
Brady Corporation beat Q1 expectations with $405.3 million in revenue and adjusted EPS of $1.21.
Ondas shares jumped nearly 20% after reporting record Q3 revenue of $10.1 million and a 17.7% reduction in net loss.
Twist Bioscience posted Q4 revenue of $99 million, beating estimates but missing on EPS at -$0.45.
Legence Corp. posted Q3 2025 revenue of $708 million, up 26% year-over-year and above expectations, and issued upbeat guidance for Q4 and 2026.
Bitfarms slid 13% after missing Q3 EPS and revenue targets and announcing a shift toward AI infrastructure at its Washington site.
Sally Beauty posted Q4 2025 EPS of $0.55 and revenue of $947 million, both above expectations, and expects steady growth in fiscal 2026.
Disney reported Q4 EPS of $1.11 alongside $22.5 billion in revenue, topping profit expectations but falling short on sales, with growth expected in 2026.
Spectrum Brands delivered Q4 EPS of $2.61 even as sales fell 5.2% and sees steady growth ahead in 2026, led by Pet Care and Home &…
Legend Biotech posted Q3 2025 EPS of -$0.11 and revenue of $272.33 million, supported by strong demand for CARVYKTI®.